InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (7 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
7
T+90 hit rate
0%
T+90 mean return
-12.7%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Patel Gautam, Director. Director active across 2 companies, notably Amneal Pharmaceuticals, Inc.. Cumulatively, 23 filings have been logged. Breakdown: 2 buys · 7 sells. Total volume traded: €3m. Activity tracked since 15 December 2021. The latest transaction was disclosed on 5 May 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations23 total
40,258 sharesClass A Common StockSEC:0001628280-25-023966:0
3,768 shares@ US$8.000.9% of flowClass A Common StockSEC:0001628280-25-022719:0
4,900 shares@ US$8.001.2% of flowClass A Common StockSEC:0001628280-25-022719:1
80,000 shares@ US$8.3020.6% of flowClass A Common StockSEC:0001628280-25-016184:0
80,000 shares@ US$8.9022.9% of flowClass A Common StockSEC:0001628280-25-010679:0
80,000 shares@ US$8.1421.3% of flowClass A Common StockSEC:0001628280-25-004064:0
62,590 shares@ US$8.0116.2% of flowClass A Common StockSEC:0001628280-25-001153:0
17,410 shares@ US$8.014.5% of flowClass A Common StockSEC:0001628280-25-000581:0
2,770 shares@ US$90.26100.0% of flowCommon StockSEC:0000109177-24-000061:0
76,453 sharesClass A Common StockSEC:0001628280-24-023241:0
33,458,067 sharesClass A Common StockSEC:0000898432-24-000011:0
3,073,298 sharesClass A Common StockSEC:0000898432-23-000827:0
3,775 shares0Common StockSEC:0000109177-23-000058:0
17,497,336 sharesClass A Common StockSEC:0001209191-23-054741:0
80,128 sharesClass A Common StockSEC:0001209191-23-028733:0
5,020 shares0Common StockSEC:0000109177-22-000046:0
35,406 sharesClass A Common StockSEC:0001209191-22-028166:0
50,000 shares@ US$4.210.0049% mcap100.0% of flowClass A Common StockSEC:0001209191-21-070646
Canonical exit: 17 Mar 2022 (T+90)
50,000 shares@ US$4.210.0049% mcap50.0% of flowClass A Common StockSEC:0001209191-21-070646:0
Canonical exit: 17 Mar 2022 (T+90)
2,441 shares0Common StockSEC:0000109177-21-000101
2,441 shares0Common StockSEC:0000109177-21-000101:0
46,218 sharesClass A Common StockSEC:0001209191-21-030813:0
46,218 sharesClass A Common StockSEC:0001209191-21-030813
23 of 23 declarations
About Patel Gautam
Gautam Patel is a Board Member at Amneal Pharmaceuticals, Inc. and Spectrum Brands Holdings, Inc. In this role, he contributes to the governance of these companies, bringing his expertise to the board. Amneal Pharmaceuticals is a pharmaceutical company, while Spectrum Brands specializes in consumer products. Mr. Patel's experience in these sectors is valuable for guiding strategic decisions.
